Three years after investing $248 million in a Type 2 diabetes joint venture with Google’s (NSDQ:GOOGL) Verily Life Sciences, , Sanofi (NYSE:SNY) is backing out. The drug company’s new CEO made the announcement during a capital markets meeting yesterday, saying the company had over-invested in the virtual diabetes clinic, Onduo, according to published reports. Sanofi will […]
Onduo taps Glytec’s insulin therapy software as part of virtual diabetes clinic
Glytec has inked a deal with Onduo to integrate the company’s Glucommander Outpatient insulin management software into Onduo’s virtual diabetes clinic. Onduo, a joint venture of Sanofi (NYSE:SNY) and Verily, is reportedly working to develop a platform that brings together medical devices, internal medicine ehr software and support from healthcare experts to help people manage their Type II diabetes. Get the […]
Sanofi, Google’s Verily launch $500m Onduo diabetes JV
Sanofi (NYSE:SNY) and Verily Life Sciences, the healthcare play owned by Google parent Alphabet (NSDQ:GOOGL), are launching a joint venture to tackle diabetes. The Cambridge, Mass.-based Onduo JV will aim to combine Verily’s expertise in miniaturized electronics, analytics, and consumer software with Sanofi’s diabetes program. Dr. Joshua Riff, formerly senior vice president of prevention & wellbeing at UnitedHealth‘s (NYSE:UNH) Optum business, was tapped to be […]
MassDevice Network
@MassDevice
LinkedIn
YouTube